nodes	percent_of_prediction	percent_of_DWPC	metapath
Naltrexone—alcohol dependence—endogenous depression	0.973	1	CtDrD
Naltrexone—OPRD1—forebrain—endogenous depression	0.00122	0.0936	CbGeAlD
Naltrexone—UGT1A1—Codeine and Morphine Metabolism—CYP2D6—endogenous depression	0.00119	0.115	CbGpPWpGaD
Naltrexone—OPRK1—forebrain—endogenous depression	0.00117	0.0898	CbGeAlD
Naltrexone—OPRM1—brainstem—endogenous depression	0.00086	0.0662	CbGeAlD
Naltrexone—OPRM1—forebrain—endogenous depression	0.00083	0.0639	CbGeAlD
Naltrexone—Methylnaltrexone—CYP2D6—endogenous depression	0.000701	0.22	CrCbGaD
Naltrexone—OPRD1—nervous system—endogenous depression	0.00066	0.0508	CbGeAlD
Naltrexone—OPRD1—central nervous system—endogenous depression	0.000636	0.0489	CbGeAlD
Naltrexone—OPRK1—nervous system—endogenous depression	0.000633	0.0487	CbGeAlD
Naltrexone—UGT1A1—endocrine gland—endogenous depression	0.000612	0.0471	CbGeAlD
Naltrexone—OPRK1—central nervous system—endogenous depression	0.000609	0.0469	CbGeAlD
Naltrexone—OPRK1—cerebellum—endogenous depression	0.000596	0.0459	CbGeAlD
Naltrexone—OPRM1—midbrain—endogenous depression	0.000548	0.0422	CbGeAlD
Naltrexone—ABCB1—Codeine and Morphine Metabolism—CYP2D6—endogenous depression	0.000546	0.0529	CbGpPWpGaD
Naltrexone—Oxymorphone—CYP2D6—endogenous depression	0.000523	0.164	CrCbGaD
Naltrexone—OPRD1—brain—endogenous depression	0.000505	0.0388	CbGeAlD
Naltrexone—OPRK1—brain—endogenous depression	0.000484	0.0372	CbGeAlD
Naltrexone—OPRM1—endocrine gland—endogenous depression	0.000481	0.037	CbGeAlD
Naltrexone—UGT1A1—Estrogen metabolism—COMT—endogenous depression	0.000472	0.0457	CbGpPWpGaD
Naltrexone—Hydrocodone—CYP2D6—endogenous depression	0.000457	0.144	CrCbGaD
Naltrexone—OPRM1—nervous system—endogenous depression	0.00045	0.0347	CbGeAlD
Naltrexone—OPRM1—central nervous system—endogenous depression	0.000434	0.0334	CbGeAlD
Naltrexone—Oxycodone—CYP2D6—endogenous depression	0.000417	0.131	CrCbGaD
Naltrexone—Buprenorphine—CYP2D6—endogenous depression	0.000384	0.121	CrCbGaD
Naltrexone—Hydromorphone—CYP2D6—endogenous depression	0.000378	0.119	CrCbGaD
Naltrexone—OPRM1—brain—endogenous depression	0.000344	0.0265	CbGeAlD
Naltrexone—Morphine—CYP2D6—endogenous depression	0.000322	0.101	CrCbGaD
Naltrexone—ABCB1—forebrain—endogenous depression	0.000239	0.0184	CbGeAlD
Naltrexone—OPRK1—Mecp2 and Associated Rett Syndrome—BDNF—endogenous depression	0.000239	0.0231	CbGpPWpGaD
Naltrexone—ABCB1—adrenal cortex—endogenous depression	0.000222	0.0171	CbGeAlD
Naltrexone—OPRM1—G-protein activation—POMC—endogenous depression	0.000216	0.0209	CbGpPWpGaD
Naltrexone—ABCB1—cardiovascular system—endogenous depression	0.000202	0.0156	CbGeAlD
Naltrexone—ABCB1—pituitary gland—endogenous depression	0.000179	0.0138	CbGeAlD
Naltrexone—OPRM1—TCR Signaling Pathway—GATA3—endogenous depression	0.000168	0.0163	CbGpPWpGaD
Naltrexone—ABCB1—adrenal gland—endogenous depression	0.00016	0.0123	CbGeAlD
Naltrexone—ABCB1—midbrain—endogenous depression	0.000158	0.0122	CbGeAlD
Naltrexone—OPRM1—IL4-mediated signaling events—IL10—endogenous depression	0.000157	0.0152	CbGpPWpGaD
Naltrexone—ABCB1—thyroid gland—endogenous depression	0.000154	0.0119	CbGeAlD
Naltrexone—ABCB1—endocrine gland—endogenous depression	0.000139	0.0107	CbGeAlD
Naltrexone—OPRD1—Peptide ligand-binding receptors—OXT—endogenous depression	0.000134	0.013	CbGpPWpGaD
Naltrexone—UGT1A1—Phase II conjugation—COMT—endogenous depression	0.000133	0.0128	CbGpPWpGaD
Naltrexone—ABCB1—nervous system—endogenous depression	0.00013	0.01	CbGeAlD
Naltrexone—ABCB1—HIF-1-alpha transcription factor network—ADM—endogenous depression	0.00013	0.0126	CbGpPWpGaD
Naltrexone—ABCB1—central nervous system—endogenous depression	0.000125	0.00962	CbGeAlD
Naltrexone—ABCB1—cerebellum—endogenous depression	0.000122	0.00941	CbGeAlD
Naltrexone—OPRK1—Peptide ligand-binding receptors—OXT—endogenous depression	0.000118	0.0114	CbGpPWpGaD
Naltrexone—UGT1A1—NRF2 pathway—SLC6A4—endogenous depression	0.000117	0.0113	CbGpPWpGaD
Naltrexone—OPRD1—G alpha (i) signalling events—HTR1A—endogenous depression	0.000109	0.0106	CbGpPWpGaD
Naltrexone—UGT1A1—Biological oxidations—CYP2D6—endogenous depression	0.000102	0.00992	CbGpPWpGaD
Naltrexone—OPRD1—GPCRs, Class A Rhodopsin-like—HTR1A—endogenous depression	0.000101	0.00979	CbGpPWpGaD
Naltrexone—UGT1A1—Metapathway biotransformation—CYP2D6—endogenous depression	0.000101	0.00978	CbGpPWpGaD
Naltrexone—OPRM1—Peptide ligand-binding receptors—OXT—endogenous depression	9.94e-05	0.00963	CbGpPWpGaD
Naltrexone—ABCB1—brain—endogenous depression	9.93e-05	0.00764	CbGeAlD
Naltrexone—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2C—endogenous depression	9.76e-05	0.00946	CbGpPWpGaD
Naltrexone—OPRK1—G alpha (i) signalling events—HTR1A—endogenous depression	9.55e-05	0.00925	CbGpPWpGaD
Naltrexone—OPRD1—Class A/1 (Rhodopsin-like receptors)—OXT—endogenous depression	9e-05	0.00872	CbGpPWpGaD
Naltrexone—OPRM1—Opioid Signalling—POMC—endogenous depression	8.95e-05	0.00868	CbGpPWpGaD
Naltrexone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR1A—endogenous depression	8.86e-05	0.00859	CbGpPWpGaD
Naltrexone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR1A—endogenous depression	8.66e-05	0.00839	CbGpPWpGaD
Naltrexone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2C—endogenous depression	8.56e-05	0.0083	CbGpPWpGaD
Naltrexone—OPRD1—GPCRs, Class A Rhodopsin-like—HTR7—endogenous depression	8.55e-05	0.00829	CbGpPWpGaD
Naltrexone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2C—endogenous depression	8.36e-05	0.0081	CbGpPWpGaD
Naltrexone—OPRD1—GPCR ligand binding—ADM—endogenous depression	8.17e-05	0.00792	CbGpPWpGaD
Naltrexone—OPRM1—G alpha (i) signalling events—HTR1A—endogenous depression	8.07e-05	0.00782	CbGpPWpGaD
Naltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—OXT—endogenous depression	7.89e-05	0.00764	CbGpPWpGaD
Naltrexone—UGT1A1—Biological oxidations—COMT—endogenous depression	7.75e-05	0.00752	CbGpPWpGaD
Naltrexone—UGT1A1—Biological oxidations—MAOA—endogenous depression	7.7e-05	0.00746	CbGpPWpGaD
Naltrexone—UGT1A1—Metapathway biotransformation—COMT—endogenous depression	7.65e-05	0.00741	CbGpPWpGaD
Naltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR1A—endogenous depression	7.59e-05	0.00736	CbGpPWpGaD
Naltrexone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR7—endogenous depression	7.5e-05	0.00727	CbGpPWpGaD
Naltrexone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR1A—endogenous depression	7.49e-05	0.00726	CbGpPWpGaD
Naltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2C—endogenous depression	7.33e-05	0.00711	CbGpPWpGaD
Naltrexone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR7—endogenous depression	7.32e-05	0.0071	CbGpPWpGaD
Naltrexone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2C—endogenous depression	7.23e-05	0.00701	CbGpPWpGaD
Naltrexone—OPRK1—GPCR ligand binding—ADM—endogenous depression	7.17e-05	0.00695	CbGpPWpGaD
Naltrexone—OPRD1—GPCR ligand binding—CRH—endogenous depression	6.85e-05	0.00664	CbGpPWpGaD
Naltrexone—OPRD1—GPCR ligand binding—OXT—endogenous depression	6.85e-05	0.00664	CbGpPWpGaD
Naltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—OXT—endogenous depression	6.67e-05	0.00646	CbGpPWpGaD
Naltrexone—OPRD1—GPCR ligand binding—HTR1A—endogenous depression	6.59e-05	0.00639	CbGpPWpGaD
Naltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR7—endogenous depression	6.42e-05	0.00622	CbGpPWpGaD
Naltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1A—endogenous depression	6.42e-05	0.00622	CbGpPWpGaD
Naltrexone—OPRD1—GPCR ligand binding—HTR2C—endogenous depression	6.37e-05	0.00617	CbGpPWpGaD
Naltrexone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR7—endogenous depression	6.34e-05	0.00614	CbGpPWpGaD
Naltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2C—endogenous depression	6.2e-05	0.00601	CbGpPWpGaD
Naltrexone—OPRD1—Peptide ligand-binding receptors—POMC—endogenous depression	6.11e-05	0.00592	CbGpPWpGaD
Naltrexone—ABCB1—Allograft Rejection—IL10—endogenous depression	6.06e-05	0.00588	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—ADM—endogenous depression	6.06e-05	0.00587	CbGpPWpGaD
Naltrexone—OPRK1—GPCR ligand binding—CRH—endogenous depression	6.01e-05	0.00582	CbGpPWpGaD
Naltrexone—OPRK1—GPCR ligand binding—OXT—endogenous depression	6.01e-05	0.00582	CbGpPWpGaD
Naltrexone—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2A—endogenous depression	5.99e-05	0.0058	CbGpPWpGaD
Naltrexone—OPRK1—GPCR ligand binding—HTR1A—endogenous depression	5.78e-05	0.0056	CbGpPWpGaD
Naltrexone—OPRK1—GPCR ligand binding—HTR2C—endogenous depression	5.58e-05	0.00541	CbGpPWpGaD
Naltrexone—OPRD1—GPCR ligand binding—HTR7—endogenous depression	5.58e-05	0.00541	CbGpPWpGaD
Naltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR7—endogenous depression	5.43e-05	0.00526	CbGpPWpGaD
Naltrexone—OPRK1—Peptide ligand-binding receptors—POMC—endogenous depression	5.36e-05	0.00519	CbGpPWpGaD
Naltrexone—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—endogenous depression	5.25e-05	0.00509	CbGpPWpGaD
Naltrexone—OPRD1—G alpha (i) signalling events—POMC—endogenous depression	5.15e-05	0.00499	CbGpPWpGaD
Naltrexone—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—endogenous depression	5.13e-05	0.00497	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—CRH—endogenous depression	5.08e-05	0.00492	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—OXT—endogenous depression	5.08e-05	0.00492	CbGpPWpGaD
Naltrexone—UGT1A1—Biological oxidations—POMC—endogenous depression	5.01e-05	0.00486	CbGpPWpGaD
Naltrexone—OPRK1—GPCR ligand binding—HTR7—endogenous depression	4.89e-05	0.00474	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—HTR1A—endogenous depression	4.89e-05	0.00474	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—HTR2C—endogenous depression	4.72e-05	0.00457	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—ADM—endogenous depression	4.62e-05	0.00448	CbGpPWpGaD
Naltrexone—OPRM1—Peptide ligand-binding receptors—POMC—endogenous depression	4.53e-05	0.00439	CbGpPWpGaD
Naltrexone—OPRK1—G alpha (i) signalling events—POMC—endogenous depression	4.52e-05	0.00438	CbGpPWpGaD
Naltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—endogenous depression	4.5e-05	0.00436	CbGpPWpGaD
Naltrexone—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—endogenous depression	4.44e-05	0.0043	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—ADM—endogenous depression	4.2e-05	0.00407	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—HTR7—endogenous depression	4.13e-05	0.00401	CbGpPWpGaD
Naltrexone—OPRD1—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	4.1e-05	0.00397	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—ADM—endogenous depression	4.05e-05	0.00393	CbGpPWpGaD
Naltrexone—OPRD1—GPCR ligand binding—HTR2A—endogenous depression	3.91e-05	0.00379	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—OXT—endogenous depression	3.87e-05	0.00375	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—CRH—endogenous depression	3.87e-05	0.00375	CbGpPWpGaD
Naltrexone—OPRM1—G alpha (i) signalling events—POMC—endogenous depression	3.82e-05	0.0037	CbGpPWpGaD
Naltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—endogenous depression	3.8e-05	0.00368	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—HTR1A—endogenous depression	3.73e-05	0.00361	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—ADM—endogenous depression	3.68e-05	0.00356	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—HTR2C—endogenous depression	3.6e-05	0.00349	CbGpPWpGaD
Naltrexone—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	3.59e-05	0.00348	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—OXT—endogenous depression	3.52e-05	0.00341	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—CRH—endogenous depression	3.52e-05	0.00341	CbGpPWpGaD
Naltrexone—OPRK1—GPCR ligand binding—HTR2A—endogenous depression	3.43e-05	0.00332	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—ADM—endogenous depression	3.42e-05	0.00332	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—CRH—endogenous depression	3.39e-05	0.00329	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—OXT—endogenous depression	3.39e-05	0.00329	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—HTR1A—endogenous depression	3.38e-05	0.00328	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—HTR2C—endogenous depression	3.27e-05	0.00317	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—HTR1A—endogenous depression	3.27e-05	0.00317	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—HTR2C—endogenous depression	3.16e-05	0.00306	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—HTR7—endogenous depression	3.15e-05	0.00305	CbGpPWpGaD
Naltrexone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—endogenous depression	3.13e-05	0.00304	CbGpPWpGaD
Naltrexone—OPRD1—GPCR ligand binding—POMC—endogenous depression	3.12e-05	0.00302	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—ADM—endogenous depression	3.11e-05	0.00301	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—CRH—endogenous depression	3.08e-05	0.00299	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—OXT—endogenous depression	3.08e-05	0.00299	CbGpPWpGaD
Naltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—endogenous depression	3.04e-05	0.00294	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—HTR1A—endogenous depression	2.97e-05	0.00288	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—HTR2A—endogenous depression	2.9e-05	0.00281	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—TPH1—endogenous depression	2.89e-05	0.0028	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—OXT—endogenous depression	2.87e-05	0.00278	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—CRH—endogenous depression	2.87e-05	0.00278	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—HTR2C—endogenous depression	2.87e-05	0.00278	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—HTR7—endogenous depression	2.86e-05	0.00277	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—HTR7—endogenous depression	2.76e-05	0.00268	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—HTR1A—endogenous depression	2.76e-05	0.00268	CbGpPWpGaD
Naltrexone—OPRK1—GPCR ligand binding—POMC—endogenous depression	2.74e-05	0.00265	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—WASF2—endogenous depression	2.71e-05	0.00263	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—HTR2C—endogenous depression	2.67e-05	0.00258	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—OXT—endogenous depression	2.61e-05	0.00252	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—CRH—endogenous depression	2.61e-05	0.00252	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—WASF1—endogenous depression	2.6e-05	0.00252	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—HTR7—endogenous depression	2.51e-05	0.00243	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—HTR1A—endogenous depression	2.51e-05	0.00243	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—ADM—endogenous depression	2.48e-05	0.0024	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—HTR2C—endogenous depression	2.42e-05	0.00235	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—WASF2—endogenous depression	2.38e-05	0.0023	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—HTR7—endogenous depression	2.34e-05	0.00226	CbGpPWpGaD
Naltrexone—OPRM1—GPCR ligand binding—POMC—endogenous depression	2.31e-05	0.00224	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—WASF1—endogenous depression	2.28e-05	0.00221	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—HTR2A—endogenous depression	2.21e-05	0.00214	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—CACNB2—endogenous depression	2.19e-05	0.00212	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—TPH2—endogenous depression	2.19e-05	0.00212	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—ADM—endogenous depression	2.17e-05	0.00211	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—DPYD—endogenous depression	2.15e-05	0.00209	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—HTR7—endogenous depression	2.12e-05	0.00206	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—CRH—endogenous depression	2.08e-05	0.00201	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—OXT—endogenous depression	2.08e-05	0.00201	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—WASF2—endogenous depression	2.01e-05	0.00195	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—HTR2A—endogenous depression	2e-05	0.00194	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—CACNA1C—endogenous depression	2e-05	0.00194	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—HTR1A—endogenous depression	2e-05	0.00194	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—HTR2A—endogenous depression	1.94e-05	0.00188	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—HTR2C—endogenous depression	1.93e-05	0.00187	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—WASF1—endogenous depression	1.93e-05	0.00187	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—ADM—endogenous depression	1.84e-05	0.00178	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—OXT—endogenous depression	1.82e-05	0.00176	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—CRH—endogenous depression	1.82e-05	0.00176	CbGpPWpGaD
Naltrexone—OPRD1—GPCR downstream signaling—POMC—endogenous depression	1.76e-05	0.00171	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—HTR2A—endogenous depression	1.76e-05	0.0017	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—HTR1A—endogenous depression	1.75e-05	0.0017	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—CYP2D6—endogenous depression	1.75e-05	0.0017	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—HTR2C—endogenous depression	1.69e-05	0.00164	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—HTR7—endogenous depression	1.69e-05	0.00164	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—HTR2A—endogenous depression	1.64e-05	0.00159	CbGpPWpGaD
Naltrexone—OPRD1—Signaling by GPCR—POMC—endogenous depression	1.6e-05	0.00155	CbGpPWpGaD
Naltrexone—OPRK1—GPCR downstream signaling—POMC—endogenous depression	1.55e-05	0.0015	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—OXT—endogenous depression	1.54e-05	0.00149	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—CRH—endogenous depression	1.54e-05	0.00149	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—HTR2A—endogenous depression	1.49e-05	0.00144	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—HTR7—endogenous depression	1.48e-05	0.00144	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—HTR1A—endogenous depression	1.48e-05	0.00144	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—HTR2C—endogenous depression	1.43e-05	0.00139	CbGpPWpGaD
Naltrexone—OPRK1—Signaling by GPCR—POMC—endogenous depression	1.4e-05	0.00136	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—COMT—endogenous depression	1.33e-05	0.00129	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—TPH1—endogenous depression	1.32e-05	0.00128	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—MAOA—endogenous depression	1.32e-05	0.00128	CbGpPWpGaD
Naltrexone—OPRM1—GPCR downstream signaling—POMC—endogenous depression	1.31e-05	0.00127	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—HTR7—endogenous depression	1.25e-05	0.00121	CbGpPWpGaD
Naltrexone—OPRM1—Signaling by GPCR—POMC—endogenous depression	1.19e-05	0.00115	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—HTR2A—endogenous depression	1.18e-05	0.00115	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—HTR2A—endogenous depression	1.04e-05	0.00101	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—TPH2—endogenous depression	1e-05	0.000973	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—CACNB2—endogenous depression	1e-05	0.000973	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—DPYD—endogenous depression	9.88e-06	0.000957	CbGpPWpGaD
Naltrexone—OPRD1—Signaling Pathways—POMC—endogenous depression	9.46e-06	0.000917	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—CACNA1C—endogenous depression	9.18e-06	0.00089	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—HTR2A—endogenous depression	8.78e-06	0.000851	CbGpPWpGaD
Naltrexone—UGT1A1—Metabolism—POMC—endogenous depression	8.57e-06	0.000831	CbGpPWpGaD
Naltrexone—OPRK1—Signaling Pathways—POMC—endogenous depression	8.29e-06	0.000804	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—CYP2D6—endogenous depression	8.03e-06	0.000778	CbGpPWpGaD
Naltrexone—OPRM1—Signaling Pathways—POMC—endogenous depression	7.01e-06	0.000679	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—COMT—endogenous depression	6.08e-06	0.00059	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—MAOA—endogenous depression	6.04e-06	0.000585	CbGpPWpGaD
Naltrexone—ABCB1—Metabolism—POMC—endogenous depression	3.93e-06	0.000381	CbGpPWpGaD
